ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

TERN Tern Plc

1.85
-0.10 (-5.13%)
01 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Tern Plc LSE:TERN London Ordinary Share GB00BFPMV798 ORD 0.02P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.10 -5.13% 1.85 1.80 1.90 1.95 1.70 1.95 2,432,881 15:46:38
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Finance Services 66k -10.45M -0.0269 -0.69 7.19M
Tern Plc is listed in the Finance Services sector of the London Stock Exchange with ticker TERN. The last closing price for Tern was 1.95p. Over the last year, Tern shares have traded in a share price range of 1.65p to 10.50p.

Tern currently has 388,571,510 shares in issue. The market capitalisation of Tern is £7.19 million. Tern has a price to earnings ratio (PE ratio) of -0.69.

Tern Share Discussion Threads

Showing 442851 to 442863 of 449200 messages
Chat Pages: Latest  17716  17715  17714  17713  17712  17711  17710  17709  17708  17707  17706  17705  Older
DateSubjectAuthorDiscuss
07/4/2024
11:11
Could the haptic experience of FVR core be implemented to produce chip placing or dice throwing sensations in online gaming etc

I’m sure plenty other possibilities exist for FVR haptics if a big enough mind/visionary with huge pockets owned it.

still waiting
07/4/2024
11:02
A decent reasonably length deal
with good numbers with one ( or more) igaming companies would help increase our value & ability to ipo at a decent multiple, thereby monetising our holding in FVR.
Been here a long time at 6-8p & missed many opportunities to sell for very decent profits but greed & belief that 1 of our holdings would yield a substantial return kept me in.Decision now is to stick or double down to reduce average to around 5p.

base7
07/4/2024
10:46
Noting Posts 348079 & 348080

I now have a slightly greater understanding of the iGaming industry in general.

I suspect that technology such as that owned and patented by FundamentalVR with its in-built support and admin systems, would be ideal for the extended iGaming sector.

If technology permits, then I could imagine Gaming clients meeting in a VR/MR casino environment, or at a VR/MR sports event, (with celebrities) all linked to host management.


NOTE: I HAVE NO IDEAS IF THIS IS FEASIBLE, ACTIONABLE, IN PROGRESS ALREADY OR IMPOSSIBLE.

However it does appear interesting?

tullynessle
07/4/2024
10:31
Re Post 348078.

At around 21:30 in from the start, Mr Nisbet talks about Hybrid Dealer Products and mentions:

- Line dealer
- dual play roulette
- High costs for set up, allocated table area, camera, dealers, etc

- opportunity large but so are costs
- business case takes a while to work through

- INNOVATION - can film games on a green screen
- lots more promotional opportunities
- very easy to get number of participants increased

- ENGAGEMENT - very easy to engage with customers

- WHATS HAPPENING IN 2024 - Omni channel
- Retail and digital together
- MGM have 30,000,000 MGM Rewards clients
- Content will continue to be King

- THROUGHOUT - Lots of talk about CLIENT EXPERIENCE

tullynessle
07/4/2024
10:24
Worth remembering that the 4 CEOs of Tern PLCs portfolio Companies just 10 days ago ALL stated that significant progress had been achieved in Q1 2024.
I am anticipating a stream of news regarding this shortly.

investor125
07/4/2024
10:21
A great insight into gaming, its operation, competitive income streams, costs and new developments within that industry.





iGaming Daily

BetMGM’s active 2023 and beyond, with Angus Nisbet / Interview 32 mins


Dec 13, 2023 iGaming Daily

The progress for getting new states to legalise online casino may have stagnated in 2023, but the iGaming industry itself is growing this year and launching a wide range of new products, verticals, and partnerships.

One of the most active brands on that front was BetMGM.

On today's episode of iGaming Daily, SBC Americas Editor, Jessica Welman is joined by BetMGM’s VP of Gaming Angus Nisbet, to talk about the brand’s busy 2023 and what to expect in 2024.

tullynessle
07/4/2024
10:17
See also next post...

It may be worth re-posting Post 348042 whilst recognising that more research is still required.

Also, to note that the technology concerned is:

"VR extensions for existing or new TV formats or development of gaming content that embraces VR / AR / MR,"


+++++++++++++++++++++++++++++++++++++


Tullynessle6 Apr '24 - 08:07 - 348042 of 348076 Edit
0 6 0
"We can work with you, along with the team at Fundamental VR...."




Primetime Play / Our Services / Virtual, Augmented and Mixed Reality


Virtual, Augmented and Mixed Reality

In collaboration with Fundamental VR, we can bring to life any aspirations your company has within Virtual / Augmented and Mixed Reality. Working with experts in this new emerging technology is an exciting proposition for PrimeTime Play and its clients. Whether your business is considering VR extensions for existing or new TV formats or development of gaming content that embraces VR / AR / MR, we can bring together a team with all the experience required to maximise content quality and business models.

If your company does not yet have a brief for a specific VR project that’s also fine.

We can work with you, along with the team at Fundamental VR, to help inform practical strategic steps and future decisions.

tullynessle
07/4/2024
09:30
Reams of utter tosh reveal the desperation here.
emigna2020
07/4/2024
07:57
Nice to see TERN rising so powerfully over the past week, glad I doubled up sub 2p....
jack ladd
06/4/2024
23:03
hxxps://www.prnewswire.com/news-releases/new-vr-solution-to-democratize-ophthalmic-surgical-training-affordable-portable-and-scalable-302108822.html?s=09

The tool is intentionally designed to train surgeons in low- and middle-income countries, home to nine out of ten people with vision loss due to the difficulty of accessing eye care

BOSTON, April 5, 2024 /PRNewswire/ -- Orbis International and FundamentalVR today launched a new immersive virtual reality (VR) training solution intentionally designed for use in low- and middle-income countries, at the American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. The tool is built to support students and residents learning to perform surgery to treat cataracts – the world's leading cause of blindness, despite being treatable with a short operation – ultimately growing the number of skilled care providers and improving outcomes for patients. The tool's affordability, portability and scalability, combined with its targeted functionality, make it a key advancement in ophthalmic surgical education globally and will accelerate Orbis's efforts to build strong and sustainable eye care systems around the world.

Orbis, a global nonprofit, teamed up with FundamentalVR, a technology company dedicated to developing VR surgical training solutions, to create this unique tool. It integrates VR, haptic feedback, cloud assessment data, and off-the-shelf hardware to create a solution for cataract surgical training in resource-limited settings. Immersive VR simulation integrated with haptics provides a highly realistic experience for eye-care professionals, who are able to practice each step repeatedly to cement their understanding of both basic and difficult techniques.

"We saw a real need that we could meet," says Dr. Hunter Cherwek, Orbis Vice President of Clinical Services and Technologies. "Most existing simulation training tools are expensive, not easily transportable or sourced, and/or train doctors on a surgical method usually only practiced in high-resource areas. Thanks to our partnership with FundamentalVR, we were able to bring a new VR solution to life that makes cataract surgical training accessible no matter where you live."

The training tool enables independent learning through automated performance monitoring and feedback, a particular benefit to medical professionals without access to robust ophthalmic training opportunities. Residents can hone their skills in a realistic simulation, practicing first in a safe environment before entering the operating room, which is proven to yield better surgical outcomes. Users of the platform can supplement their learning with Cybersight, Orbis's telemedicine and e-learning platform.

"Our partnership with Orbis International not only underscores our commitment to advancing the field of ophthalmology but also highlights the immense potential of VR in creating safer, more effective learning environments for healthcare professionals," said Richard Vincent, co-founder and CEO of FundamentalVR. "Our goal is to elevate patient outcomes and redefine the standard of surgical proficiency on a global scale, advancing the quality of healthcare across borders."

The tool's use of affordable gaming hardware makes it more financially accessible to resource-restricted partners. Additionally, it focuses on manual small-incision cataract surgery, the most common technique performed in low-resource countries, in order to train eye care professionals in the procedure they are most likely to use, making them better equipped to treat patients in their own communities.

The Orbis-FundamentalVR tool is already in use at partner hospitals in Bangladesh, China, Mongolia, Ethiopia, and India, where it is fast becoming an essential element of eye care education. Orbis is working with Bangladesh to incorporate surgery simulation into its national ophthalmology training curriculum, helping it become the third country in the world to mandate its use for eye care education.

The tool has been featured in a recent campaign as an example of how the metaverse is helping transform industries, including healthcare.

In the future, Orbis aims to utilize VR solutions to help train medical professionals in the treatment of glaucoma, strabismus and other eye conditions, further expanding access to eye care around the world.

The new training tool was developed with funding from the Silicon Valley Orbis Innovation Fund established by John A. and Susan Sobrato, Connie and Bob Lurie, Dr. David F. and Victoria A. Chang, and the ASCRS Foundation.

About Orbis

Orbis is an international nonprofit delivering sight-saving programs in over 200 countries and regions worldwide so that individuals, families, and communities can thrive. Currently, around 1 billion people across the globe live with completely avoidable blindness and vision loss. For over four decades, Orbis has been tackling this challenge by building strong and sustainable eye care systems that leave a lasting legacy of vision. Orbis runs dedicated in-country programs in Africa, Asia, the Caribbean, and Latin America; develops and implements innovative training and technology, including an award-winning telemedicine and e-learning platform, Cybersight; and operates the world's first and only Flying Eye Hospital, a fully accredited ophthalmic teaching hospital on board an MD-10 aircraft. For the past ten consecutive years, Orbis has achieved Charity Navigator's coveted four-star rating for demonstrating strong financial health and commitment to accountability and transparency, placing Orbis in the top 3% of U.S. charities. For the past two years, Orbis has earned GuideStar's platinum Seal of Transparency. In 2022, Orbis earned "accredited charity" status from the Better Business Bureau by meeting all 20 of their standards for charity accountability. To learn more, please visit orbis.org.

About FundamentalVR

Global leader in immersive surgical training, FundamentalVR was founded with the mission to accelerate human capability in surgery and medicine through virtual technologies to improve patient outcomes. The company's innovative approach accelerates the industry shift towards digital surgery, addressing the competency gap in training for intelligent operating rooms. Its purpose-built Fundamental platform allows for full rehearsal of medical and surgical procedures, and its patented HapticVRTM technology mimics the physical touch, weight, resistance and feedback of surgical actions and accurately simulates the sensations of soft tissue, bone textures and muscle. With over 15,000 competency-building sessions conducted globally and accredited by and affiliated with institutions like AAO, AAOS and Royal College of Surgeons of England, FundamentalVR remains committed to elevating performance and training skilled surgeons and OR teams at scale. For more information, please visit FundamentalVR.com

MEDIA CONTACT
Orbis International
Jenna Montgomery
Manager, Global Communications and Marketing
jenna.montgomery@orbis.org

FundamentalVR
Alessandra Fusar Poli
Publicist
alessandra@lobeline.com

SOURCE Orbis International

walval
06/4/2024
22:22
stentorian6 Apr '24 - 11:01 - 348058 of 348072

I said that FVR would be more lucrative in VR porn than medical training years ago. The mass market consumer applications vastly outweigh what is a very niche application that they are currently targeting.

I do see the logic on their approach though. As I previously mentioned, the funding for r&d would not be available from the porn industry.

cmackay
06/4/2024
22:02
Buying up to 8p
Next week I’m told 😉

shares188
06/4/2024
17:25
Re Post 348071

Some very powerful statements from TM.

I have to say the future appears very exciting.


* "Drug-GPT does not just adapt to the current state of healthcare marketing; it advances it."

* "This Advanced Data Science and Artificial Intelligence solution embodies the future of strategic marketing,"

* "For Strategists seeking clarity amidst complexity, Drug-GPT is not just a tool—it is an essential partner."

* "Explore how Drug-GPT can transform your healthcare marketing strategy into an informed, data-driven powerhouse."


Talking Medicines / The Fusion of AI and Strategy in Healthcare Marketing


Extract:

The Holistic Impact of Drug-GPT in Healthcare Marketing

Drug-GPT’s holistic approach to healthcare marketing presents a paradigm of innovation, providing a new dimension of strategic insight. Each analyzer is meticulously designed to address specific pain points encountered by strategists. Drug-GPT curates diverse conversational data into a strategic asset. By curating diverse Conversational Data into a strategic asset, Drug-GPT empowers Strategists to navigate the complexities of the healthcare landscape with precision and purpose.

As AI matures, its role in healthcare marketing extends beyond automation to enhancing human decision-making, ensuring strategies are both informed and impactful. Drug-GPT does not just adapt to the current state of healthcare marketing; it advances it. This Advanced Data Science and Artificial Intelligence solution embodies the future of strategic marketing, where data clarity, audience insight, and message precision are realities made possible by the fusion of AI and data science.

For Strategists seeking clarity amidst complexity, Drug-GPT is not just a tool—it is an essential partner. Explore how Drug-GPT can transform your healthcare marketing strategy into an informed, data-driven powerhouse. Book in your personalized demo here.

tullynessle
Chat Pages: Latest  17716  17715  17714  17713  17712  17711  17710  17709  17708  17707  17706  17705  Older